Menu
GWAS Study

Genetic variants linked to statin-associated Type 2 diabetes mellitus: Findings from the UK Biobank and the All of Us Research Program.

Park YA, Lee DH, Kim JS et al.

40754711 PubMed ID
GWAS Study Type
110674 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

PY
Park YA
LD
Lee DH
KJ
Kim JS
YJ
Yee J
GH
Gwak HS
Chapter II

Abstract

Summary of the research findings

Background and purpose: Statins are widely prescribed for the prevention of cardiovascular disease, yet recent studies suggest an increased risk of new-onset Type 2 diabetes mellitus. This study aimed to identify genetic variants associated with statin-associated new-onset Type 2 diabetes mellitus from the UK Biobank and All of Us.

6,524 European ancestry cases, 49,505 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

110674
Total Participants
GWAS
Study Type
Yes
Replicated
12,185 European ancestry cases, 42,460 European ancestry controls
Replication Participants
European
Ancestry
U.K., U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.